<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Subst Abuse</journal-id><journal-id journal-id-type="iso-abbrev">Subst Abuse</journal-id><journal-id journal-id-type="pmc-domain-id">1861</journal-id><journal-id journal-id-type="pmc-domain">sart</journal-id><journal-id journal-id-type="publisher-id">SAT</journal-id><journal-title-group><journal-title>Substance Abuse: Research and Treatment</journal-title></journal-title-group><issn pub-type="epub">1178-2218</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10326463</article-id><article-id pub-id-type="pmcid-ver">PMC10326463.1</article-id><article-id pub-id-type="pmcaid">10326463</article-id><article-id pub-id-type="pmcaiid">10326463</article-id><article-id pub-id-type="pmid">37426878</article-id><article-id pub-id-type="doi">10.1177/11782218231182552</article-id><article-id pub-id-type="publisher-id">10.1177_11782218231182552</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title>New Patients in Treatment for Opioid Addiction in
Spain</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Pulido</surname><given-names initials="J">Jose</given-names></name><xref rid="aff1-11782218231182552" ref-type="aff">1</xref><xref rid="aff2-11782218231182552" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pastor-Moreno</surname><given-names initials="G">Guadalupe</given-names></name><xref rid="aff2-11782218231182552" ref-type="aff">2</xref><xref rid="aff3-11782218231182552" ref-type="aff">3</xref><xref rid="aff4-11782218231182552" ref-type="aff">4</xref><xref rid="corresp1-11782218231182552" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guerras</surname><given-names initials="JM">Juan Miguel</given-names></name><xref rid="aff2-11782218231182552" ref-type="aff">2</xref><xref rid="aff5-11782218231182552" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Belza</surname><given-names initials="MJ">Mar&#237;a Jos&#233;</given-names></name><xref rid="aff2-11782218231182552" ref-type="aff">2</xref><xref rid="aff5-11782218231182552" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>C&#225;ceres</surname><given-names initials="A">Ana</given-names></name><xref rid="aff6-11782218231182552" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cea-Soriano</surname><given-names initials="L">Luc&#237;a</given-names></name><xref rid="aff1-11782218231182552" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sordo</surname><given-names initials="L">Luis</given-names></name><xref rid="aff1-11782218231182552" ref-type="aff">1</xref><xref rid="aff2-11782218231182552" ref-type="aff">2</xref></contrib></contrib-group><aff id="aff1-11782218231182552"><label>1</label>Public Health and Maternal Health
Department, Faculty of Medicine, Complutense University of Madrid, Madrid,
Spain</aff><aff id="aff2-11782218231182552"><label>2</label>CIBER of Epidemiology and Public Health
(CIBERESP), Madrid, Spain</aff><aff id="aff3-11782218231182552"><label>3</label>Andalusian School of Public Health
(EASP), Granada, Spain</aff><aff id="aff4-11782218231182552"><label>4</label>Biohealth Research Institute of
Granada, Ibs. Granada, Granada, Spain</aff><aff id="aff5-11782218231182552"><label>5</label>National School of Health, Carlos III
Institute, Madrid, Spain</aff><aff id="aff6-11782218231182552"><label>6</label>Institute of Addiction, City Council of
Madrid, Madrid, Spain</aff><author-notes><corresp id="corresp1-11782218231182552">Guadalupe Pastor-Moreno, Andalusian School
of Public Health, Campus Universitario de Cartuja, Apdo, 2070, Cuesta del
Observatorio 4, Granada 18080, Spain. Email:
<email>guadalupe.pastor.easp@juntadeandalucia.es</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>6</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>17</volume><issue-id pub-id-type="pmc-issue-id">425274</issue-id><elocation-id>11782218231182552</elocation-id><history><date date-type="received"><day>14</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>06</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>08</day><month>07</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-10 11:25:17.937"><day>10</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted.
Manuscript content on this site is licensed under Creative Commons
Licenses</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which
permits non-commercial use, reproduction and distribution of the work
without further permission provided the original work is attributed as
specified on the SAGE and Open Access pages (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_11782218231182552.pdf"/><abstract><sec id="section1-11782218231182552"><title>Introduction:</title><p>Patients seeking first time treatment for opioid consumption reflect the
characteristics of the consumer population. This group has not been studied
in Spain in decades. The objective of this study was to characterize the
opioid user population seeking first time treatment (incidents) and compare
them group with those with prior treatment (prevalents).</p></sec><sec id="section2-11782218231182552"><title>Methods:</title><p>Cross-sectional study (N&#8201;=&#8201;3325) with patients with opioid addiction seeking
care at public addiction centers in the Community of Madrid from 2017
through 2019. Differentiation and comparisons were carried out using
bivariate analysis, adjusted by sociodemographic characteristics related and
those related to substance use consumption in incident and prevalent
patients.</p></sec><sec id="section3-11782218231182552"><title>Results:</title><p>About 12.2% were incidents. Compared to prevalents, there were more
foreigners (34.1% vs 19.1% <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001), but with a better
social network. Regarding opioid use, incidents were less likely to use
injection (10.7% compared to 16.8% <italic toggle="yes">P</italic>&#8201;=&#8201;.008), but had
greater daily frequency (75.8% vs 52.2%, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). The
age of initial consumption was greater (27&#8201;years vs 21.3&#8201;years,
(<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001)). About 15.5% of incidents sought care
for non-heroin opioids, compared to 4.8% of prevalents
(<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). Women sought care at twice the rate of men
(29.3% vs 12.3%; <italic toggle="yes">P</italic>&#8201;&gt;&#8201;.001).</p></sec><sec id="section4-11782218231182552"><title>Discussion:</title><p>New patients presented a profile with many stable characteristics, but which
highlighted an increase in the use of other opioids, as occurs in the
international context. Surveillance of the new patient characteristics can
serve as an early indicator of consumption changes in. Thus, periodic
monitoring is important.</p></sec></abstract><kwd-group><kwd>Opioids</kwd><kwd>heroin</kwd><kwd>opioid use disorder</kwd><kwd>substance-related disorders</kwd><kwd>social support</kwd></kwd-group><funding-group specific-use="FundRef"><award-group id="award1-11782218231182552"><funding-source id="funding1-11782218231182552"><institution-wrap><institution>Instituto de Salud Carlos III</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004587</institution-id></institution-wrap></funding-source><award-id rid="funding1-11782218231182552">PI19/00982</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2023</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section5-11782218231182552"><title>Introduction</title><p>Opioid use, especially heroin use, has been an enormous problem in Europe and in
Spain in the past 40&#8201;years.<sup><xref rid="bibr1-11782218231182552" ref-type="bibr">1</xref>,<xref rid="bibr2-11782218231182552" ref-type="bibr">2</xref></sup>
In Spain recreational use of opioids reached its highest incidence of problematic
use in the 1980s.<sup><xref rid="bibr2-11782218231182552" ref-type="bibr">2</xref>,<xref rid="bibr3-11782218231182552" ref-type="bibr">3</xref></sup>
Since then, there has been a continuous decrease.<sup>
<xref rid="bibr3-11782218231182552" ref-type="bibr">3</xref>
</sup> Current estimates indicate that 0.1% of the population has consumed opioids
in the past thirty days, a trend that has been stable since 2005.<sup><xref rid="bibr2-11782218231182552" ref-type="bibr">2</xref>,<xref rid="bibr3-11782218231182552" ref-type="bibr">3</xref></sup></p><p>The profile of drug users of the1980s and 1990s consumed heroin, was male, born in
Spain, young, and a polydrug user with a significant level of disease related to
injected use.<sup><xref rid="bibr4-11782218231182552" ref-type="bibr">4</xref>,<xref rid="bibr5-11782218231182552" ref-type="bibr">5</xref></sup> From the end of
the 1990s to 2010 the profile changed very little.<sup>
<xref rid="bibr6-11782218231182552" ref-type="bibr">6</xref>
</sup> However, there are no studies focused on the new profile of drug consumers.
Characteristics of newer users are diluted among those of people who began consuming
years ago.<sup>
<xref rid="bibr7-11782218231182552" ref-type="bibr">7</xref>
</sup> In an international context of flourishing opioid use other than heroin,<sup>
<xref rid="bibr1-11782218231182552" ref-type="bibr">1</xref>
</sup> knowledge of these characteristics is of interest. A new user profile could
be useful to identify novel characteristics and to monitor trends in the consumer population.<sup>
<xref rid="bibr8-11782218231182552" ref-type="bibr">8</xref>
</sup></p><p>The objective of this study was to describe opioid users who seek treatment for the
first time and compare it with those who have sought prior treatment, considering
the type of substance.</p></sec><sec sec-type="methods" id="section6-11782218231182552"><title>Methods</title><p>A cross-sectional study was carried out in all of the Public Centers of Addiction
Care in the Community of Madrid (Spain) between 2017 and 2019. The study population
included patients that entered treatment and were diagnosed with opioid addiction
(either opioids only or accompanied by another addiction).</p><p>The main variable was whether it was a person&#8217;s first treatment [&#8220;new patients&#8221; (NP)]
or not [&#8220;old patients&#8221; (OP)]. This information was collected from patients&#8217; medical
records when they entered treatment. Patients were asked whether this was their
first treatment or not, without specifying whether any previous treatment had been
carried out in public or private centers.</p><p>Sociodemographic variables, opioid and other substance use, and human
immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection status were
determined.</p><p>A descriptive analysis was carried out of all of the variables, followed by a
bivariate analysis of the characteristics of our sample, controlling for the main
variable (NP or OP). The &#967;<sup>2</sup> test (or Fisher exact test where appropriate)
was used for the qualitative independent variables. Finally, a multivariate analysis
(dependent variable was NP or OP) was carried out using logistic regression. The
adjustment variables included sex and those variables with significance less than
0.1 in the bivariate analysis.</p><p>We also analyzed the type of opioid (heroin or other) that had resulted in seeking
care, by sex, for both the incident cases as well as the prevalent cases.</p></sec><sec sec-type="results" id="section7-11782218231182552"><title>Results</title><p>This study included 3325 patients entering into treatment (12.2% NP, 87.8% OP). <xref rid="table1-11782218231182552" ref-type="table">Table 1</xref> shows the
characteristics of the patients in the study.</p><table-wrap position="float" id="table1-11782218231182552" orientation="portrait"><label>Table 1.</label><caption><p>Sociodemographic and opioid use characteristics related to consumption
patterns of patients in treatment for opioid use (n&#8201;=&#8201;3325).</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11782218231182552-table1.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="left" colspan="2" rowspan="1">Total</th><th align="left" colspan="2" rowspan="1">New patients (n&#8201;=&#8201;393)</th><th align="left" colspan="2" rowspan="1">Old patients (n&#8201;=&#8201;2932)</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> unadjusted</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> adjusted<sup>
<xref rid="table-fn3-11782218231182552" ref-type="table-fn">c</xref>
</sup></th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">n</th><th align="left" rowspan="1" colspan="1">%</th><th align="left" rowspan="1" colspan="1">N</th><th align="left" rowspan="1" colspan="1">%</th><th align="left" rowspan="1" colspan="1">n</th><th align="left" rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td colspan="9" rowspan="1">Sex</td></tr><tr><td rowspan="1" colspan="1">&#8195;Men</td><td rowspan="1" colspan="1">2669</td><td rowspan="1" colspan="1">80.3</td><td rowspan="1" colspan="1">318</td><td rowspan="1" colspan="1">80.9</td><td rowspan="1" colspan="1">2351</td><td rowspan="1" colspan="1">80.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Women</td><td rowspan="1" colspan="1">656</td><td rowspan="1" colspan="1">19.7</td><td rowspan="1" colspan="1">75</td><td rowspan="1" colspan="1">19.1</td><td rowspan="1" colspan="1">581</td><td rowspan="1" colspan="1">19.8</td><td rowspan="1" colspan="1">.787</td><td rowspan="1" colspan="1">.983</td></tr><tr><td colspan="9" rowspan="1">Age (years)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#10877;35</td><td rowspan="1" colspan="1">738</td><td rowspan="1" colspan="1">22.2</td><td rowspan="1" colspan="1">152</td><td rowspan="1" colspan="1">38.7</td><td rowspan="1" colspan="1">586</td><td rowspan="1" colspan="1">20.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;36-49</td><td rowspan="1" colspan="1">1688</td><td rowspan="1" colspan="1">50.8</td><td rowspan="1" colspan="1">171</td><td rowspan="1" colspan="1">43.5</td><td rowspan="1" colspan="1">1517</td><td rowspan="1" colspan="1">51.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#10878;50</td><td rowspan="1" colspan="1">898</td><td rowspan="1" colspan="1">27.0</td><td rowspan="1" colspan="1">70</td><td rowspan="1" colspan="1">17.8</td><td rowspan="1" colspan="1">828</td><td rowspan="1" colspan="1">28.2</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td colspan="9" rowspan="1">Country of birth</td></tr><tr><td rowspan="1" colspan="1">&#8195;Spanish</td><td rowspan="1" colspan="1">2546</td><td rowspan="1" colspan="1">79.0</td><td rowspan="1" colspan="1">257</td><td rowspan="1" colspan="1">65.9</td><td rowspan="1" colspan="1">2289</td><td rowspan="1" colspan="1">80.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Other</td><td rowspan="1" colspan="1">675</td><td rowspan="1" colspan="1">21.0</td><td rowspan="1" colspan="1">133</td><td rowspan="1" colspan="1">34.1</td><td rowspan="1" colspan="1">542</td><td rowspan="1" colspan="1">19.1</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td colspan="9" rowspan="1">Employment status</td></tr><tr><td rowspan="1" colspan="1">&#8195;Working</td><td rowspan="1" colspan="1">780</td><td rowspan="1" colspan="1">23.5</td><td rowspan="1" colspan="1">103</td><td rowspan="1" colspan="1">26.2</td><td rowspan="1" colspan="1">677</td><td rowspan="1" colspan="1">23.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Not working</td><td rowspan="1" colspan="1">2545</td><td rowspan="1" colspan="1">76.6</td><td rowspan="1" colspan="1">290</td><td rowspan="1" colspan="1">73.8</td><td rowspan="1" colspan="1">2255</td><td rowspan="1" colspan="1">76.9</td><td rowspan="1" colspan="1">.297</td><td rowspan="1" colspan="1">.543</td></tr><tr><td colspan="9" rowspan="1">Education level</td></tr><tr><td rowspan="1" colspan="1">&#8195;Primary or less</td><td rowspan="1" colspan="1">1591</td><td rowspan="1" colspan="1">47.8</td><td rowspan="1" colspan="1">210</td><td rowspan="1" colspan="1">53.4</td><td rowspan="1" colspan="1">1381</td><td rowspan="1" colspan="1">47.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Secondary or more</td><td rowspan="1" colspan="1">1734</td><td rowspan="1" colspan="1">52.2</td><td rowspan="1" colspan="1">183</td><td rowspan="1" colspan="1">46.6</td><td rowspan="1" colspan="1">1551</td><td rowspan="1" colspan="1">52.9</td><td rowspan="1" colspan="1">.02</td><td rowspan="1" colspan="1">.15</td></tr><tr><td colspan="9" rowspan="1">Place of residence</td></tr><tr><td rowspan="1" colspan="1">&#8195;House or apartment</td><td rowspan="1" colspan="1">2268</td><td rowspan="1" colspan="1">68.2</td><td rowspan="1" colspan="1">295</td><td rowspan="1" colspan="1">75.1</td><td rowspan="1" colspan="1">1973</td><td rowspan="1" colspan="1">67.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Others<sup>
<xref rid="table-fn1-11782218231182552" ref-type="table-fn">a</xref>
</sup></td><td rowspan="1" colspan="1">1057</td><td rowspan="1" colspan="1">31.8</td><td rowspan="1" colspan="1">98</td><td rowspan="1" colspan="1">24.9</td><td rowspan="1" colspan="1">959</td><td rowspan="1" colspan="1">32.7</td><td rowspan="1" colspan="1">.002</td><td rowspan="1" colspan="1">.414</td></tr><tr><td colspan="9" rowspan="1">Living situation</td></tr><tr><td rowspan="1" colspan="1">&#8195;Alone</td><td rowspan="1" colspan="1">722</td><td rowspan="1" colspan="1">21.7</td><td rowspan="1" colspan="1">78</td><td rowspan="1" colspan="1">19.8</td><td rowspan="1" colspan="1">644</td><td rowspan="1" colspan="1">22.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Family</td><td rowspan="1" colspan="1">1650</td><td rowspan="1" colspan="1">49.6</td><td rowspan="1" colspan="1">236</td><td rowspan="1" colspan="1">60.1</td><td rowspan="1" colspan="1">1414</td><td rowspan="1" colspan="1">48.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Others<sup>
<xref rid="table-fn2-11782218231182552" ref-type="table-fn">b</xref>
</sup></td><td rowspan="1" colspan="1">953</td><td rowspan="1" colspan="1">28.7</td><td rowspan="1" colspan="1">79</td><td rowspan="1" colspan="1">20.1</td><td rowspan="1" colspan="1">874</td><td rowspan="1" colspan="1">29.8</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">.1</td></tr><tr><td colspan="9" rowspan="1">Marital status</td></tr><tr><td rowspan="1" colspan="1">&#8195;Married/married in fact</td><td rowspan="1" colspan="1">622</td><td rowspan="1" colspan="1">18.7</td><td rowspan="1" colspan="1">109</td><td rowspan="1" colspan="1">27.7</td><td rowspan="1" colspan="1">513</td><td rowspan="1" colspan="1">17.5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Other</td><td rowspan="1" colspan="1">2703</td><td rowspan="1" colspan="1">81.3</td><td rowspan="1" colspan="1">284</td><td rowspan="1" colspan="1">72.3</td><td rowspan="1" colspan="1">2419</td><td rowspan="1" colspan="1">82.5</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">.002</td></tr><tr><td colspan="9" rowspan="1">Children</td></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">780</td><td rowspan="1" colspan="1">23.5</td><td rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1">18.3</td><td rowspan="1" colspan="1">708</td><td rowspan="1" colspan="1">24.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;No</td><td rowspan="1" colspan="1">2545</td><td rowspan="1" colspan="1">76.5</td><td rowspan="1" colspan="1">321</td><td rowspan="1" colspan="1">81.7</td><td rowspan="1" colspan="1">2224</td><td rowspan="1" colspan="1">75.9</td><td rowspan="1" colspan="1">.011</td><td rowspan="1" colspan="1">.088</td></tr><tr><td colspan="9" rowspan="1">Source of reference to addiction center</td></tr><tr><td rowspan="1" colspan="1">&#8195;Own initiative</td><td rowspan="1" colspan="1">1831</td><td rowspan="1" colspan="1">55.1</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">57.5</td><td rowspan="1" colspan="1">1605</td><td rowspan="1" colspan="1">54.7</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Others&#8217; initiative</td><td rowspan="1" colspan="1">1494</td><td rowspan="1" colspan="1">44.9</td><td rowspan="1" colspan="1">167</td><td rowspan="1" colspan="1">42.6</td><td rowspan="1" colspan="1">1327</td><td rowspan="1" colspan="1">45.3</td><td rowspan="1" colspan="1">.001</td><td rowspan="1" colspan="1">.008</td></tr><tr><td colspan="9" rowspan="1">Primary opioid of use</td></tr><tr><td rowspan="1" colspan="1">&#8195;Heroin</td><td rowspan="1" colspan="1">3122</td><td rowspan="1" colspan="1">93.9</td><td rowspan="1" colspan="1">332</td><td rowspan="1" colspan="1">84.5</td><td rowspan="1" colspan="1">2790</td><td rowspan="1" colspan="1">95.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Non-heroin</td><td rowspan="1" colspan="1">203</td><td rowspan="1" colspan="1">6.1</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">15.5</td><td rowspan="1" colspan="1">142</td><td rowspan="1" colspan="1">4.8</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td colspan="9" rowspan="1">Age of initial consumption (years)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#10877;24</td><td rowspan="1" colspan="1">2131</td><td rowspan="1" colspan="1">70.2</td><td rowspan="1" colspan="1">172</td><td rowspan="1" colspan="1">47.0</td><td rowspan="1" colspan="1">1959</td><td rowspan="1" colspan="1">73.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&gt;24</td><td rowspan="1" colspan="1">903</td><td rowspan="1" colspan="1">29.8</td><td rowspan="1" colspan="1">194</td><td rowspan="1" colspan="1">53.0</td><td rowspan="1" colspan="1">709</td><td rowspan="1" colspan="1">26.6</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td colspan="9" rowspan="1">Frequency of use</td></tr><tr><td rowspan="1" colspan="1">&#8195;Every day</td><td rowspan="1" colspan="1">1828</td><td rowspan="1" colspan="1">55.0</td><td rowspan="1" colspan="1">298</td><td rowspan="1" colspan="1">75.8</td><td rowspan="1" colspan="1">1530</td><td rowspan="1" colspan="1">52.2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Not every day</td><td rowspan="1" colspan="1">1497</td><td rowspan="1" colspan="1">45.0</td><td rowspan="1" colspan="1">95</td><td rowspan="1" colspan="1">24.2</td><td rowspan="1" colspan="1">1402</td><td rowspan="1" colspan="1">47.8</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">&lt;.001</td></tr><tr><td colspan="9" rowspan="1">Injection</td></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">534</td><td rowspan="1" colspan="1">16.1</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">10.7</td><td rowspan="1" colspan="1">492</td><td rowspan="1" colspan="1">16.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;No</td><td rowspan="1" colspan="1">2791</td><td rowspan="1" colspan="1">83.9</td><td rowspan="1" colspan="1">351</td><td rowspan="1" colspan="1">89.3</td><td rowspan="1" colspan="1">2440</td><td rowspan="1" colspan="1">83.2</td><td rowspan="1" colspan="1">.002</td><td rowspan="1" colspan="1">.008</td></tr><tr><td colspan="9" rowspan="1">Addicted to 2 substances</td></tr><tr><td rowspan="1" colspan="1">&#8195;No</td><td rowspan="1" colspan="1">1767</td><td rowspan="1" colspan="1">53.1</td><td rowspan="1" colspan="1">230</td><td rowspan="1" colspan="1">58.5</td><td rowspan="1" colspan="1">1537</td><td rowspan="1" colspan="1">52.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">1558</td><td rowspan="1" colspan="1">46.9</td><td rowspan="1" colspan="1">163</td><td rowspan="1" colspan="1">41.5</td><td rowspan="1" colspan="1">1395</td><td rowspan="1" colspan="1">47.6</td><td rowspan="1" colspan="1">.026</td><td rowspan="1" colspan="1">.006</td></tr><tr><td colspan="9" rowspan="1">Use of cocaine (past month)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">1502</td><td rowspan="1" colspan="1">45.2</td><td rowspan="1" colspan="1">153</td><td rowspan="1" colspan="1">38.9</td><td rowspan="1" colspan="1">1349</td><td rowspan="1" colspan="1">46.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;No</td><td rowspan="1" colspan="1">1823</td><td rowspan="1" colspan="1">54.8</td><td rowspan="1" colspan="1">240</td><td rowspan="1" colspan="1">61.1</td><td rowspan="1" colspan="1">1583</td><td rowspan="1" colspan="1">54.0</td><td rowspan="1" colspan="1">.01</td><td rowspan="1" colspan="1">.006</td></tr><tr><td colspan="9" rowspan="1">Use of cannabis (past month)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">310</td><td rowspan="1" colspan="1">9.3</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">7.1</td><td rowspan="1" colspan="1">282</td><td rowspan="1" colspan="1">9.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;No</td><td rowspan="1" colspan="1">3015</td><td rowspan="1" colspan="1">90.7</td><td rowspan="1" colspan="1">365</td><td rowspan="1" colspan="1">92.9</td><td rowspan="1" colspan="1">2650</td><td rowspan="1" colspan="1">90.4</td><td rowspan="1" colspan="1">.11</td><td rowspan="1" colspan="1">.042</td></tr><tr><td colspan="9" rowspan="1">Use of alcohol (past month)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">284</td><td rowspan="1" colspan="1">8.5</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">6.1</td><td rowspan="1" colspan="1">260</td><td rowspan="1" colspan="1">8.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;No</td><td rowspan="1" colspan="1">3041</td><td rowspan="1" colspan="1">91.5</td><td rowspan="1" colspan="1">369</td><td rowspan="1" colspan="1">93.9</td><td rowspan="1" colspan="1">2672</td><td rowspan="1" colspan="1">91.1</td><td rowspan="1" colspan="1">.117</td><td rowspan="1" colspan="1">.017</td></tr><tr><td colspan="9" rowspan="1">HIV</td></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">531</td><td rowspan="1" colspan="1">16.0</td><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">4.1</td><td rowspan="1" colspan="1">515</td><td rowspan="1" colspan="1">17.6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;No/unknown</td><td rowspan="1" colspan="1">2794</td><td rowspan="1" colspan="1">84.0</td><td rowspan="1" colspan="1">377</td><td rowspan="1" colspan="1">95.9</td><td rowspan="1" colspan="1">2417</td><td rowspan="1" colspan="1">82.4</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">.01</td></tr><tr><td colspan="9" rowspan="1">HCV</td></tr><tr><td rowspan="1" colspan="1">&#8195;Yes</td><td rowspan="1" colspan="1">1190</td><td rowspan="1" colspan="1">35.8</td><td rowspan="1" colspan="1">46</td><td rowspan="1" colspan="1">11.7</td><td rowspan="1" colspan="1">1144</td><td rowspan="1" colspan="1">69.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;No/unknown</td><td rowspan="1" colspan="1">2135</td><td rowspan="1" colspan="1">64.2</td><td rowspan="1" colspan="1">347</td><td rowspan="1" colspan="1">88.3</td><td rowspan="1" colspan="1">1788</td><td rowspan="1" colspan="1">61.0</td><td rowspan="1" colspan="1">&lt;.001</td><td rowspan="1" colspan="1">&lt;.001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-11782218231182552"><label>a</label><p>Institutions or homeless.</p></fn><fn id="table-fn2-11782218231182552"><label>b</label><p>Institutions, friends, or others.</p></fn><fn id="table-fn3-11782218231182552"><label>c</label><p>Adjusted by: Age, sex, country of birth, place of residence, and marital
status; HIV; Opioid; Frequency of use and method.</p></fn></table-wrap-foot></table-wrap><p>In terms of sociodemographic variables, NP were younger
(<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001), with a greater proportion of people born outside of
Spain (34.1% vs 19.1%, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001), and a greater likelihood of
being married (27.7% vs 17.5%, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). NP were more likely to
be seeking care due to their own initiative, rather than being sent to treatment by
family members (<italic toggle="yes">P</italic>&#8201;=&#8201;.008). No differences were found in other
variables such as sex, unemployment, educational level, place of residence, living
situation, or having children.</p><p>Regarding opioid use, injection use was less frequent among NP (10.7% vs 16.8%
<italic toggle="yes">P</italic>&#8201;=&#8201;.008), but daily consumption of opioids was greater (75.8%
vs 52.2%, <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). The average age of initiation of
consumption was lower among OP (21.3&#8201;years vs 27; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001).
Overall, heroin was the most frequently used opioid (93.9%). Nevertheless, 15.5% of
NP sought care for addiction to other opioids, compared to 4.8% of OP
(<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). In the analysis by sex, women in the NP sought
care for an opioid other than heroin at a rate double that of men (29.3% vs 12.3%;
<italic toggle="yes">P</italic>&#8201;&gt;&#8201;.001), while no such difference was observed among OP
(6.0% vs 4.6%; <italic toggle="yes">P</italic>&#8201;=&#8201;.16; <xref rid="fig1-11782218231182552" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="fig1-11782218231182552" orientation="portrait"><label>Figure 1.</label><caption><p>Primary opioid of consumption by times seeking treatment and gender.</p><p>*New Patients were those who sought treatment for the first time. **Old
patients were those who had done so before.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11782218231182552-fig1.jpg"/></fig><p>In terms of use of other substances, there were lower levels of co-addiction to 2
substances among NP (41.5% vs 47.6%, <italic toggle="yes">P</italic>&#8201;=&#8201;.006) and a lower
consumption of cocaine, cannabis, or alcohol in the past month
(<italic toggle="yes">P</italic>&#8201;=&#8201;.006, .042, and .017). Finally, the number of VIH and HCV
positive patients was lower among NP compared to OP
(<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.01).</p></sec><sec sec-type="discussion" id="section8-11782218231182552"><title>Discussion</title><p>This study is the first in decades to focus on new patients addicted to opioids in
Spain and the first to differentiate these patients from those who have received
prior treatment. Despite that the profile of patients with new opioid addictions
presents many stable characteristics compared to patients with a prior history of
treatment, we have observed an increase among new patients in the demand for
treatment for opioids other than heroin, especially among women.</p><p>Not all those who begin to consume opioids require treatment, and not all those who
need treatment seek it out, but there is a correlation between these populations.
Those who are in treatment are a reflection of the larger group.<sup>
<xref rid="bibr8-11782218231182552" ref-type="bibr">8</xref>
</sup> Thus, these results can serve as a proxy to a new patient profile.</p><p>Regarding the characteristics of the study population, both user age and age of
initiation of opioid consumption suggests that new users are beginning opioid use
more than 5&#8201;years later than prior generations.<sup><xref rid="bibr4-11782218231182552" ref-type="bibr">4</xref>,<xref rid="bibr5-11782218231182552" ref-type="bibr">5</xref>,<xref rid="bibr9-11782218231182552" ref-type="bibr">9</xref></sup> Finally, in terms of
nationality, nearly 35% of NP was foreign-born, nearly double the percent among OP,
and more than double the percent documented in recent studies.<sup>
<xref rid="bibr10-11782218231182552" ref-type="bibr">10</xref>
</sup> Although the foreign-born population in Spain has increased in recent
decades, it still represents less than 15% of the total Spanish population.<sup>
<xref rid="bibr11-11782218231182552" ref-type="bibr">11</xref>
</sup> Thus, the higher proportion of foreign-born among new patients is not simply
due to demographic change. Periodic monitoring of patient profiles, especially sex,
nationality, and age of initiation of consumption can serve to detect changes in
drug use patterns, to implement prevention policies, and to support access to the
health system for users.<sup>
<xref rid="bibr2-11782218231182552" ref-type="bibr">2</xref>
</sup></p><p>In this study NP seemed to have a better social network as well as a greater
likelihood of living with a partner. This corresponds to what has been described in
other studies that indicate that a greater number of years of opioid use is
associated with a weaker social network.<sup><xref rid="bibr8-11782218231182552" ref-type="bibr">8</xref>,<xref rid="bibr9-11782218231182552" ref-type="bibr">9</xref></sup></p><p>While heroin is the principal opioid of 94% of all users, the rate among NP is lower,
at 84.5% (70.7% in women and 87.7% in men). During the years when this information
was collected, there did not seem to be an upturn in opioid consumption in Spain.<sup>
<xref rid="bibr6-11782218231182552" ref-type="bibr">6</xref>
</sup> What these figures suggest, and which agrees with the international context,<sup>
<xref rid="bibr1-11782218231182552" ref-type="bibr">1</xref>
</sup> is that although heroin continues to be the primary opioid in terms of
general addition, other opioids are beginning to play a relevant role in addiction
processes, especially among women. This finding could be explained by the so-called
&#8220;telescope effect,&#8221; in which women tend to progress more rapidly from their first
use to problematic use and from problematic use to needing treatment.<sup><xref rid="bibr8-11782218231182552" ref-type="bibr">8</xref>,<xref rid="bibr12-11782218231182552" ref-type="bibr">12</xref></sup></p><p>In Spain, injection is no longer the main route of opioid use as it was decades
ago,<sup><xref rid="bibr2-11782218231182552" ref-type="bibr">2</xref>,<xref rid="bibr4-11782218231182552" ref-type="bibr">4</xref>,<xref rid="bibr5-11782218231182552" ref-type="bibr">5</xref></sup> which is reflected in this
study. However, more than 10% of NP inject. In comparison with Europe,<sup>
<xref rid="bibr1-11782218231182552" ref-type="bibr">1</xref>
</sup> Spain&#8217;s rate of injection use is considered low, but we should not stop being
vigilant.<sup><xref rid="bibr2-11782218231182552" ref-type="bibr">2</xref>,<xref rid="bibr9-11782218231182552" ref-type="bibr">9</xref></sup>
In this study we also observed a greater daily consumption of opioids among NP, but
with lower levels of co-addiction and/or consumption of other substances, which has
also been shown in prior studies.<sup><xref rid="bibr4-11782218231182552" ref-type="bibr">4</xref>,<xref rid="bibr5-11782218231182552" ref-type="bibr">5</xref></sup> Cocaine continues to stand out
as the other substance that requires response. Complete treatment cannot be
considered without addressing the use of other substances.</p><p>This study has the limitations of any cross-sectional study. In addition, this study
was conducted in public treatment centers, therefore private centers (which are very scarce)<sup>
<xref rid="bibr13-11782218231182552" ref-type="bibr">13</xref>
</sup> are not represented. Finally, in terms of the representativeness of these
results in the Spanish context, prior studies in users that combine information from
different Spanish regions have shown that the findings can be extrapolated to the
entire territory.<sup><xref rid="bibr5-11782218231182552" ref-type="bibr">5</xref>,<xref rid="bibr10-11782218231182552" ref-type="bibr">10</xref></sup></p><p>This study focuses on new patients, who represent more than 10% of the overall
population. Knowing their characteristics allows us to establish new user profiles
and provides the opportunity to detect trends and develop preventive measures,
especially in the context of an increase in the prescription of opioid medications.<sup>
<xref rid="bibr14-11782218231182552" ref-type="bibr">14</xref>
</sup></p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Author Contributions:</bold> Jos&#233; Pulido: Conceptualization, data curation, formal analysis, investigation,
writing &#8211; original draft. Guadalupe Pastor-Moreno: Formal analysis, methodology,
software, writing &#8211; review and editing. Guerras, Juan Miguel, C&#225;ceres Ana and
Cea-Soriano Luc&#237;a: Conceptualization, methodology, resources. Belza, Mar&#237;a Jos&#233;:
Methodology, supervision, writing &#8211; review and editing. Sordo, Luis:
Conceptualization, methodology, resources, supervision, writing &#8211; original
draft.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This study has been
funded by Instituto de Salud Carlos III (ISCIII) through the project &#8220;
PI19/00982&#8221; and co-funded by the European Union.</p></fn><fn fn-type="COI-statement"><p>The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-11782218231182552"><label>1</label><mixed-citation publication-type="journal"><collab>European Monitoring Centre for
Drugs and Drug Addiction</collab>. <article-title>Drug-related deaths and
mortality in Europe</article-title>. <source>Update from the EMCDDA expert
network;</source><year>2021</year>.</mixed-citation></ref><ref id="bibr2-11782218231182552"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#225;nchez-Niub&#242;</surname><given-names>A</given-names></name><name name-style="western"><surname>Fortiana</surname><given-names>J</given-names></name><name name-style="western"><surname>Barrio</surname><given-names>G</given-names></name><name name-style="western"><surname>Suelves</surname><given-names>JM</given-names></name><name name-style="western"><surname>Correa</surname><given-names>JF</given-names></name><name name-style="western"><surname>Domingo-Salvany</surname><given-names>A.</given-names></name></person-group><article-title>Problematic heroin use incidence trends in
Spain</article-title>. <source>Addiction</source>.
<year>2009</year>;<volume>104</volume>:<fpage>248</fpage>-<lpage>255</lpage>.<pub-id pub-id-type="pmid">19149821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1360-0443.2008.02451.x</pub-id></mixed-citation></ref><ref id="bibr3-11782218231182552"><label>3</label><mixed-citation publication-type="journal"><collab>Observatorio Espa&#241;ol de las
Drogas y las Adicciones</collab>. <article-title>Informe 2018. Alcohol,
tabaco y drogas ilegales en Espa&#241;a. Encuesta sobre uso de drogas en
ense&#241;anzas secundarias en Espa&#241;a (ESTUDES), 1994&#8211;2020</article-title>.
<source>Ministerio de Sanidad, Consumo y Bienestar Social, Delegaci&#243;n para
el Plan Nacional sobre Drogas;</source><year>2020</year>.</mixed-citation></ref><ref id="bibr4-11782218231182552"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madoz-G&#250;rpide</surname><given-names>A</given-names></name><name name-style="western"><surname>Ochoa</surname><given-names>E.</given-names></name></person-group><article-title>Opiate dependence users profile. A decade
review</article-title>. <source>Actas Esp Psiquiatr</source>.
<year>2003</year>;<volume>31</volume>:<fpage>263</fpage>-<lpage>271</lpage>.<pub-id pub-id-type="pmid">14557951</pub-id></mixed-citation></ref><ref id="bibr5-11782218231182552"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#225;nchez-Carbonell</surname><given-names>X</given-names></name><name name-style="western"><surname>Seus</surname><given-names>L.</given-names></name></person-group><article-title>Ten-year survival analysis of a cohort of heroin
addicts in Catalonia: the EMETYST project</article-title>.
<source>Addiction</source>.
<year>2000</year>;<volume>95</volume>:<fpage>941</fpage>-<lpage>948</lpage>.<pub-id pub-id-type="pmid">10946442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1360-0443.2000.95694110.x</pub-id></mixed-citation></ref><ref id="bibr6-11782218231182552"><label>6</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez Or&#243;</surname><given-names>DP</given-names></name></person-group>. <source>Opioides En Espa&#241;a. Ni Repunte de Hero&#237;na Ni Crisis de
Opioides a La Americana</source> [<trans-source xml:lang="en">Opioids in
Spain. Neither a heroin spike nor an American-style opioid
crisis</trans-source>]. <publisher-name>Episteme. Investigaci&#243;n e
Intervenci&#243;n social</publisher-name>; <year>2019</year>.</mixed-citation></ref><ref id="bibr7-11782218231182552"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molist</surname><given-names>G</given-names></name><name name-style="western"><surname>Brugal</surname><given-names>MT</given-names></name><name name-style="western"><surname>Barrio</surname><given-names>G</given-names></name></person-group>, <etal>et al</etal>. <article-title>Effect of ageing and time
since first heroin and cocaine use on mortality from external and natural
causes in a Spanish cohort of drug users</article-title>. <source>Int J Drug
Policy</source>.
<year>2018</year>;<volume>53</volume>:<fpage>8</fpage>-<lpage>16</lpage>.<pub-id pub-id-type="pmid">29268239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugpo.2017.11.011</pub-id></mixed-citation></ref><ref id="bibr8-11782218231182552"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sartor</surname><given-names>CE</given-names></name><name name-style="western"><surname>Kranzler</surname><given-names>HR</given-names></name><name name-style="western"><surname>Gelernter</surname><given-names>J.</given-names></name></person-group><article-title>Rate of progression from first use to dependence
on cocaine or opioids: a cross-substance examination of associated
demographic, psychiatric, and childhood risk factors</article-title>.
<source>Addict Behav</source>.
<year>2014</year>;<volume>39</volume>:<fpage>473</fpage>-<lpage>479</lpage>.<pub-id pub-id-type="pmid">24238782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addbeh.2013.10.021</pub-id><pub-id pub-id-type="pmcid">PMC3855905</pub-id></mixed-citation></ref><ref id="bibr9-11782218231182552"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nordt</surname><given-names>C</given-names></name><name name-style="western"><surname>Wiessing</surname><given-names>L</given-names></name><name name-style="western"><surname>Kuijpers</surname><given-names>W</given-names></name></person-group>, <etal>et al</etal>. <article-title>Long-term opioid agonist
treatment participation after first treatment entry is similar across 4
European regions but lower in non-nationals</article-title>. <source>Eur
Addict Res</source>.
<year>2018</year>;<volume>24</volume>:<fpage>173</fpage>-<lpage>183</lpage>.<pub-id pub-id-type="pmid">30016806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000490529</pub-id></mixed-citation></ref><ref id="bibr10-11782218231182552"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valencia</surname><given-names>J</given-names></name><name name-style="western"><surname>Alvaro-Meca</surname><given-names>A</given-names></name><name name-style="western"><surname>Troya</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>High rates of early HCV
reinfection after DAA treatment in people with recent drug use attended at
mobile harm reduction units</article-title>. <source>Int J Drug
Policy</source>.
<year>2019</year>;<volume>72</volume>:<fpage>181</fpage>-<lpage>188</lpage>.<pub-id pub-id-type="pmid">31253391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugpo.2019.06.016</pub-id></mixed-citation></ref><ref id="bibr11-11782218231182552"><label>11</label><mixed-citation publication-type="webpage"><collab>Spanish National Statistics
Institute</collab>. <article-title>Official website of the Spanish National
Statistics Institute</article-title>. <year>2020</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ine.es/jaxiT3/Tabla.htm?t=33844&amp;L=0" ext-link-type="uri">https://www.ine.es/jaxiT3/Tabla.htm?t=33844&amp;L=0</ext-link></mixed-citation></ref><ref id="bibr12-11782218231182552"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keyes</surname><given-names>KM</given-names></name><name name-style="western"><surname>Martins</surname><given-names>SS</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>C</given-names></name><name name-style="western"><surname>Hasin</surname><given-names>DS.</given-names></name></person-group><article-title>Telescoping and gender differences in alcohol
dependence: new evidence from two national surveys</article-title>.
<source>Am J Psychiatry</source>.
<year>2010</year>;<volume>167</volume>(<issue>8</issue>):<fpage>969</fpage>-<lpage>976</lpage>.<pub-id pub-id-type="pmid">20439391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ajp.2009.09081161</pub-id><pub-id pub-id-type="pmcid">PMC3767417</pub-id></mixed-citation></ref><ref id="bibr13-11782218231182552"><label>13</label><mixed-citation publication-type="webpage"><collab>Descripci&#243;n de las caracter&#237;sticas de
los pacientes incluidos en el registro acumulativo de drogodependientes
(RAD)</collab>. <article-title>Comunidad de Madrid 2020</article-title>.
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.comunidad.madrid/sites/default/files/doc/sanidad/drog/2020_descripcion_de_las_caracteristicas_de_los_pacientes_incluidos_en_el_registro_acumulativo_de_drogodendientes_rad_c_madrid_2020.pdf" ext-link-type="uri">https://www.comunidad.madrid/sites/default/files/doc/sanidad/drog/2020_descripcion_de_las_caracteristicas_de_los_pacientes_incluidos_en_el_registro_acumulativo_de_drogodendientes_rad_c_madrid_2020.pdf</ext-link></mixed-citation></ref><ref id="bibr14-11782218231182552"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salazar</surname><given-names>A</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>S</given-names></name><name name-style="western"><surname>De Sola</surname><given-names>H</given-names></name><name name-style="western"><surname>Moral-Munoz</surname><given-names>JA</given-names></name><name name-style="western"><surname>Due&#241;as</surname><given-names>M</given-names></name><name name-style="western"><surname>Failde</surname><given-names>I.</given-names></name></person-group><article-title>The evolution of opioid-related mortality and
potential years of life lost in Spain from 2008 to 2017: differences between
Spain and the United States</article-title>. <source>Curr Med Res
Opin</source>.
<year>2020</year>;<volume>36</volume>(<issue>2</issue>):<fpage>285</fpage>-<lpage>291</lpage>.<pub-id pub-id-type="pmid">31635485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/03007995.2019.1684251</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>